165 related articles for article (PubMed ID: 1351849)
61. Effects of raubasine stereoisomers on pre- and postsynaptic alpha-adrenoceptors in the rat vas deferens.
Demichel P; Roquebert J
Br J Pharmacol; 1984 Oct; 83(2):505-10. PubMed ID: 6091834
[TBL] [Abstract][Full Text] [Related]
62. Dissociation of presynaptic alpha 2-adrenoceptors following prazosin administration: presynaptic effect of prazosin.
Vizi ES; Ludvig N; Rónai AZ; Folly G
Eur J Pharmacol; 1983 Nov; 95(3-4):287-90. PubMed ID: 6317415
[TBL] [Abstract][Full Text] [Related]
63. Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens.
Campos M; de Lucena Morais P; Pupo AS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):72-8. PubMed ID: 12845422
[TBL] [Abstract][Full Text] [Related]
64. Evidence that dopamine is acting at alpha-adrenoceptors of the rat vas deferens.
Miranda HF; Wolstenholme WW; Moreu GM; Cuevas N; Bustamante D
J Recept Res; 1990; 10(5-6):317-32. PubMed ID: 1964177
[TBL] [Abstract][Full Text] [Related]
65. Electrochemical and electrophysiological analysis of the effects of SK&F 104078 on prejunctional alpha 2-adrenoceptors.
Bao JX; Gonon F; Stjärne L
Eur J Pharmacol; 1991 Oct; 203(2):159-63. PubMed ID: 1686858
[TBL] [Abstract][Full Text] [Related]
66. Changes in prejunctional potency of B-HT 933 during aging in the rat vas deferens.
Pagenkopf CW; Bourreau JP; Challice CE
Clin Exp Pharmacol Physiol; 1990 Aug; 17(8):557-65. PubMed ID: 2170068
[TBL] [Abstract][Full Text] [Related]
67. Newly synthesized alpha 1-adrenoceptor blockers (SM911 and SM2470) and characterization of alpha-adrenoceptors in rat aortic strips, rat vas deferens preparations and rabbit aortic strips.
Takayanagi I; Konno F; Arai H; Chimoto K; Kitada T
Gen Pharmacol; 1985; 16(6):613-5. PubMed ID: 2867950
[TBL] [Abstract][Full Text] [Related]
68. A difference in the affinity of some selective alpha 2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit.
Lattimer N; Rhodes KF
Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):278-81. PubMed ID: 2862589
[TBL] [Abstract][Full Text] [Related]
69. Analysis of agonism at functional prejunctional alpha 2-adrenoceptors of rat vas deferens using operational and null approaches.
Sallés J; Giraldo J; Badia A
Eur J Pharmacol; 1994 Jun; 258(3):229-38. PubMed ID: 7916302
[TBL] [Abstract][Full Text] [Related]
70. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
[TBL] [Abstract][Full Text] [Related]
71. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE
Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730
[TBL] [Abstract][Full Text] [Related]
72. Submandibular gland acinar cells express multiple alpha1-adrenoceptor subtypes.
Bockman CS; Bruchas MR; Zeng W; O'Connell KA; Abel PW; Scofield MA; Dowd FJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):364-72. PubMed ID: 15265978
[TBL] [Abstract][Full Text] [Related]
73. The influence of neuronal uptake upon the relative potencies of agonists acting at prejunctional alpha 2-adrenoceptors in the rat isolated vas deferens.
Warming SE; Shipley SD; Leedham JA; Hartley ML; Handberg GM; Pennefather JN
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):14-30. PubMed ID: 6129831
[TBL] [Abstract][Full Text] [Related]
74. Prejunctional inhibitory dopamine receptors in the rat isolated vas deferens.
Tayo FM
Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):28-37. PubMed ID: 6121537
[TBL] [Abstract][Full Text] [Related]
75. Alterations in prejunctional adrenoceptor function in guinea pig and rat vas deferens after chronic ganglionic blockade.
Sax RD; Westfall TC
J Pharmacol Exp Ther; 1981 Oct; 219(1):21-6. PubMed ID: 6116794
[TBL] [Abstract][Full Text] [Related]
76. Alpha 2-autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation.
Bohmann C; Schollmeyer P; Rump LC
Br J Pharmacol; 1993 Jan; 108(1):262-8. PubMed ID: 8094025
[TBL] [Abstract][Full Text] [Related]
77. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney.
Uhlén S; Wikberg JE
Br J Pharmacol; 1991 Nov; 104(3):657-64. PubMed ID: 1665747
[TBL] [Abstract][Full Text] [Related]
78. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
[TBL] [Abstract][Full Text] [Related]
79. Origin of ATP release in the rat vas deferens: concomitant measurement of [3H]noradrenaline and [14C]ATP.
Vizi ES; Burnstock G
Eur J Pharmacol; 1988 Dec; 158(1-2):69-77. PubMed ID: 2851460
[TBL] [Abstract][Full Text] [Related]
80. Evidence that SK & F 104078 does not differentiate between pre- and postjunctional alpha 2-adrenoceptors.
Connaughton S; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):379-82. PubMed ID: 2907608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
